King's College London

Research portal

Structural covariance of cortical gyrification at illness onset in Treatment Resistance: A longitudinal study of first-episode psychoses

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalSchizophrenia bulletin
Accepted/In press10 Mar 2021

King's Authors


Treatment-resistance (TR) in patients with first episode psychosis (FEP) is a major cause of disability and functional impairment, yet mechanisms underlying this severe disorder are poorly understood. As one view is that TR has neurodevelopmental roots, we investigated whether its emergence relates to disruptions in synchronized cortical maturation quantified using gyrification-based connectomes. Seventy patients with FEP evaluated at their first presentation to psychiatric services were followed-up using clinical records for 4 years; of these, 17 (24.3%) met the definition of TR and 53 (75.7%) remained non-TR at 4 years. Structural MRI images were obtained within 5 weeks from first exposure to antipsychotics. Local gyrification indices were computed for 148 contiguous cortical regions using FreeSurfer; each subject’s contribution to group-based structural covariance was quantified using a jack-knife procedure, providing a single deviation matrix for each subject. The latter was used to derive topological properties that were compared between TR and non-TR patients using a Functional Data Analysis approach. Compared to the non-TR patients, TR patients showed a significant reduction in small-worldness (Hedges’s g=2.09, P<.001) and a reduced clustering coefficient (Hedges’s g=1.07, P<.001) with increased length (Hedges’s g=-2.17, P<.001), indicating a disruption in the organizing principles of cortical folding. The positive symptom burden was higher in patients with more pronounced small-worldness (r=0.41, P=.001) across the entire sample. The trajectory of synchronised cortical development inferred from baseline MRI-based structural covariance highlights the possibility of identifying patients at high-risk of treatment resistance prospectively, based on individualised gyrification-based connectomes.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454